Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
CYCyclo Therapeutics, Inc. logo

Cyclo Therapeutics, Inc. (CYTH)

NASDAQ Capital Market · Currency in USD
$0.72 ▲ +0.00 (+0.00%)
At close: Mar 26, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.72
Open
$0.72
Day's Range
$0.72 – $0.72
52 Week Range
$0.55 – $1.62
Volume
186,806
Avg. Volume
1,864,521
Market Cap
$23.59M
Beta (5Y Monthly)
-0.57
PE Ratio (TTM)
--
EPS (TTM)
-$1.23
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$0.95

Profile: Cyclo Therapeutics, Inc.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-time employees
8
CEO
N. Scott Fine

Cyclo Therapeutics, Inc. operates as a clinical-stage biotechnology enterprise focused on developing treatments derived from cyclodextrins for various health conditions. Its flagship therapeutic candidate, Trappsol Cyclo, holds orphan drug status and is presently in Phase III clinical trials targeting Niemann-Pick Type C disease. The company is also investigating Trappsol Cyclo's efficacy in addressing Alzheimer's disease.

Earnings

DateEst.Actual
Nov 14, 2024-$0.17-$0.26Miss
Aug 14, 2024-$0.14-$0.21Miss
May 15, 2024-$0.20-$0.15Beat
Mar 18, 2024-$0.21-$0.23Miss
Nov 14, 2023-$0.27-$0.29Miss
Aug 15, 2023-$0.44-$0.33Beat

Analyst view

Consensus price target
$0.95 ▲ +31.8%
Range $0.95 – $0.95
Rating: Hold
Buy 33% · Hold 67% · Sell 0%

Get free alerts on CYTH and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.